Concepedia

Robert D. Dillard

RD

Statistics

Publications

28

Citations

1.1K

H-Index

17

Active since

1961

Affiliations

Eli Lilly (United States)(Current)

Robert D. Dillard is an author at Eli Lilly (United States) specializing in pharmacology, medicinal chemistry, and structure-activity relationships.

Publications per year

1961–1999

28

Publications

28

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

Richard W. Schevitz, Nicholas J. Bach, D. G. CARLSON et al. · Nature Structural & Molecular Biology · 1995 · 215 citations · Full text

, , +13

Synthesis and antiinflammatory activity of some 2,2-dimethyl-1,2-dihydroquinolines

Robert D. Dillard, D. E. Pavey, D. N. Benslay · Journal of Medicinal Chemistry · 1973 · 135 citations

, , +7

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A<sub>2</sub>. 3. Indole-3-glyoxamides

Susan E. Draheim, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Medicinal Chemistry · 1996 · 91 citations · Full text

, , +10

Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI

David W. Snyder, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 88 citations

, , +15

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A<sub>2</sub>. 1. Indole-3-acetamides

Robert D. Dillard, Nicholas J. Bach, Susan E. Draheim et al. · Journal of Medicinal Chemistry · 1996 · 70 citations

, , +14

1–5 of 28